Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression [Phase 3]
A Phase 3 trial evaluating an adequate tuberculosis regimen in hospitalized HIV-infected patients with severe immune suppression has complet…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention [Phase 1]
Phase 1 study from Stanford evaluating point-of-care pharmacogenomic testing to tailor isoniazid dosing for tuberculosis prevention; study c…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients [Phase 4]
Phase 4 clinical trial update comparing daily rifapentine plus isoniazid for 1 month (1HP) versus weekly high-dose rifapentine plus isoniazi…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
A completed Johns Hopkins-sponsored study investigates biodistribution and pharmacokinetics of pretomanid in tuberculosis patients using 18F…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis [Phase 2]
Phase 2 trial evaluating safety and efficacy of RUTI® in combination with standard tuberculosis therapy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM) [NA]
Clinical trial update describing the development of a diagnostic prediction score for tuberculosis in hospitalized children with severe acut…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia) [NA]
Clinical trial update on the completion of the TB-Speed Pneumonia study assessing systematic early tuberculosis detection using Xpert MTB/RI…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin [Phase 1]
A Phase 1 clinical trial update examining how dolutegravir behaves pharmacokinetically in HIV-infected children coinfected with tuberculosis…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Start Taking Action For TB Diagnosis
This entry reports that a Liverpool School of Tropical Medicine-led trial for improving tuberculosis diagnosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
This clinical trial update reports on the use of acoustic cough monitoring to manage patients with known respiratory diseases; the study sta…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
A clinical trial update reporting pharmacokinetic properties of antiretroviral and anti-tuberculosis drugs during pregnancy and postpartum.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
A completed clinical trial investigates the impact of parasites and dietary factors on tuberculosis. It also covers related conditions such …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function [Phase 1]
Phase 1, single-dose pharmacokinetic study comparing pretomanid in participants with renal impairment to those with normal renal function; r…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis [Phase 2]
Phase 2 trial evaluating the early bactericidal activity, safety and tolerability of oral GSK3036656 in combination with other antitubercula…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: 6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province [NA]
A clinical trial is evaluating a 6-month regimen using bedaquiline, delamanid, linezolid, and levofloxacin in rifampicin-resistant tuberculo…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa [NA]
This completed trial compared CAD4TB TB screening alone to CAD4TB screening with a CRP triage test, followed by Xpert MTB/RIF Ultra. The stu…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
A completed clinical trial evaluated the diagnostic accuracy of CAD4TB software and a C-reactive protein assay as triage tests for pulmonary…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia [Phase 2, Phase 3]
A clinical trial update reports a Phase 2/Phase 3 study evaluating empirical treatment for cytomegalovirus and tuberculosis in HIV-infected …
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis [Phase 3]
Phase 3 pharmacokinetic/pharmacodynamic study evaluating high-dose rifapentine and moxifloxacin for tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Zinc and Selenium Bioactivity [NA]
A completed clinical trial from the University of Lahore evaluated zinc and selenium bioactivity in the context of immunomodulatory drugs an…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
A completed clinical trial evaluates decortication in complex pleural empyema, with focus on multidrug-resistant infections and tuberculosis…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Video-observed Therapy for Active Tuberculosis: a Feasibility Study [NA]
A completed feasibility study evaluating video-observed therapy as a strategy to support adherence in active tuberculosis.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Cali Sin Tos Aim 2 [NA]
This clinical trial update reports completed results for a Yale University tuberculosis study (NCT06338462); results were posted on 2025-08-…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study [Phase 2]
Phase 2 CLO-FAST trial evaluating shorter regimens containing clofazimine and rifapentine for drug-susceptible tuberculosis was terminated, …
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age [Phase 1]
Phase 1 pharmacokinetic study evaluating a combined oral contraceptive alone and in combination with GSK3036656 in female participants of no…